Thibaut Mongon, CEO of Kenvue Inc. Johnson & Johnson’s consumer-health business, poses with the leadership team during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. REUTERS/Brendan McDermid
Thibaut Mongon, CEO of Kenvue Inc. Johnson & Johnson’s consumer-health business, poses with the leadership team during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. REUTERS/Brendan McDermid